The Lancet Microbe
banner
lancetmicrobe.bsky.social
The Lancet Microbe
@lancetmicrobe.bsky.social
The Lancet Microbe is an #OpenAccess journal publishing innovative and practice-changing research and opinion in clinical #microbiology

🌐 thelancet.com/journals/lanmic/home
Pinned
Our December issue is now online:

www.thelancet.com/journals/lan...

Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #Bordetela #pertussis #scabies #Neisseria #Chlamydia #HIV #TB #AMR #phage #Mycoplasma #Ebola

#IDSky #ClinMicro #OA
Reposted by The Lancet Microbe
🗨️ “Vaccines have done more to improve public health than any other medical intervention.”

A Viewpoint focuses on cancer vaccines and the future of immunotherapy: spkl.io/63322AYP7k
December 31, 2025 at 11:03 AM
New review article

Human #metapneumovirus prevention within reach: advances in vaccines and monoclonal antibodies

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #ViroSky #HMPV #OpenAccess #OA
December 24, 2025 at 9:27 PM
New personal view article

Strengthening #hepatitis B virus clinical research in Africa: the need for multistakeholder collaboration, funding, and political will

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #ViroSky #HBV #OpenAccess #OA
December 24, 2025 at 9:22 PM
New research article

Genomic determinants of antibiotic resistance for #Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #AMR #OpenAccess #OA
December 24, 2025 at 9:44 AM
Reposted by The Lancet Microbe
Our December issue is now online:

www.thelancet.com/journals/lan...

Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #Bordetela #pertussis #scabies #Neisseria #Chlamydia #HIV #TB #AMR #phage #Mycoplasma #Ebola

#IDSky #ClinMicro #OA
December 23, 2025 at 8:14 AM
Our December issue is now online:

www.thelancet.com/journals/lan...

Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #Bordetela #pertussis #scabies #Neisseria #Chlamydia #HIV #TB #AMR #phage #Mycoplasma #Ebola

#IDSky #ClinMicro #OA
December 23, 2025 at 8:14 AM
New personal view article

The need for interconnected global biorepositories from #tuberculosis studies to address fundamental questions at scale

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #TB #OpenAccess #OA
December 22, 2025 at 9:03 PM
New review article

Global biological sample collections from #tuberculosis studies: a scoping review

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #TB #OpenAccess #OA
December 22, 2025 at 8:58 PM
Reposted by The Lancet Microbe
Our January issue is now live! www.thelancet.com/journals/lan...

Featuring content on #HIV #Diabetes #MaternalMortality #CervicalCancer #Malaria #PretermBirth #EyeHealth #Alcohol #InjectingDrugUse

We wish you a peaceful end to 2025 🕊️
December 19, 2025 at 5:16 PM
Reposted by The Lancet Microbe
📢 December issue now online featuring #asthma, #pneumonia, #sepsis, #epilepsy, #HIV, #PCOS, #depression, #UTI, and much more with our editorial on the future of prostate cancer screening

…all available #free #OpenAccess❗️

Read more here: www.thelancet.com/issue/S2589-...

Attribution: Getty
#MedSky
December 19, 2025 at 12:20 PM
Reposted by The Lancet Microbe
A picture is worth a thousand words 📷

In our final issue of 2025, explore the winning photos of The Lancet's 2025 Highlights competition, representing a year of pursuing health and hope in challenging conditions.

Access the full issue: spkl.io/63327Aci33
December 19, 2025 at 12:03 PM
Reposted by The Lancet Microbe
Read our January issue!

Featuring Sotrovimab in hospitalised COVID-19 patients, global policy responses to antimicrobial resistance, and evaluating dengue vaccination in Brazilian adolescents

www.thelancet.com/issue/S1473-...
December 18, 2025 at 9:27 AM
Reposted by The Lancet Microbe
EBV and #SLE: causal or concurrence?

Read our Jan 2026 editorial bit.ly/49hm6I4
#Medsky #Rheumsky
December 17, 2025 at 5:41 PM
Reposted by The Lancet Microbe
New comment

First efficacy evidence for a multistage malaria vaccine targeting infection and transmission

www.thelancet.com/journals/lan...
First efficacy evidence for a multistage malaria vaccine targeting infection and transmission
In The Lancet Infectious Diseases, Mamady Kone and colleagues report the immunogenicity and efficacy of the ProC6C-AlOH/Matrix-M malaria vaccine evaluated in a phase 2 randomised controlled trial in 3...
www.thelancet.com
December 17, 2025 at 9:54 AM
Reposted by The Lancet Microbe
New Research

Efficacy of ProC6C-AlOH/Matrix-M against Plasmodium falciparum infection and mosquito transmission: a phase 2, randomised, controlled human malaria infection study

www.thelancet.com/journals/lan...
Efficacy of ProC6C-AlOH/Matrix-M against Plasmodium falciparum infection and mosquito transmission: a phase 2, randomised, controlled human malaria infection study
This is the first clinical trial of an anti-PfCSP subunit vaccine that has shown greater than 50% vaccine efficacy against CHMI at 12 weeks after the last vaccine dose, associated with a novel, strong...
www.thelancet.com
December 17, 2025 at 9:54 AM
Reposted by The Lancet Microbe
New Research

Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

www.thelancet.com/journals/lan...
Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
This comprehensive analysis underscores both the gains achieved through vaccination and the challenges that remain in controlling the LRI burden globally. Furthermore, it demonstrates persistent dispa...
www.thelancet.com
December 16, 2025 at 9:10 AM
New research article

Attachment and replication of clade 2.3.4.4b #influenza A (#H5N1) viruses in human respiratory epithelium: an in-vitro study

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #ViroSky #OpenAccess #OA
December 15, 2025 at 2:13 PM
Reposted by The Lancet Microbe
New single dose oral treatment for gonorrhoea effectively combats drug-resistant infections, trial finds.

Find out more 👉 spkl.io/63326AizOe
December 14, 2025 at 11:33 AM
Reposted by The Lancet Microbe
The December 2025 issue of The Lancet Regional Health - Americas is now available online: lnkd.in/gf4aXrfm

In this issue, we covered #NeglectedTropicalDiseases, #Type5Diabetes, #Mortality, #Dementia, #ChagasCardiomyopathy, #Mpox, #RSV, #Psychosis, #RespiratoryProtection, and much more.
December 13, 2025 at 10:01 PM
New research article

Fast-acting single-dose vesicular stomatitis virus-Sudan virus #vaccine: a challenge study in macaques

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #ViroSky #Ebola #OpenAccess #OA
December 11, 2025 at 12:00 PM
New research article

Impact of a multicomponent training intervention (Clean FrontLine) on microbiological cleanliness in Cambodian referral hospitals: a multicentre, stepped-wedge, cluster-randomised trial

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #IPC #OpenAccess #OA
December 11, 2025 at 9:28 AM
Reposted by The Lancet Microbe
New podcast🚨we discuss the risks of a future surge in vCJD cases, what it means for public health policy, and biomarker and treatment advances with Prof Simon Mead @smead2.bsky.social
open.spotify.com/episode/1M2A...
podcasts.apple.com/us/podcast/s...
Read more: www.thelancet.com/journals/lan...
www.thelancet.com
December 9, 2025 at 1:13 PM
Reposted by The Lancet Microbe
Linked comment: Chikungunya adolescent vaccination and the distinct risk–benefit landscapes

www.thelancet.com/journals/lan...
Chikungunya adolescent vaccination and the distinct risk–benefit landscapes
Chikungunya virus is expanding globally, with outbreaks reported across Africa, Asia, and the Americas, and locally acquired infections documented in Europe.1 To date, 104 countries have reported tran...
www.thelancet.com
December 9, 2025 at 2:01 PM
Reposted by The Lancet Microbe
New research: Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in adolescents: final results from a 12-month, double-blind, randomised, placebo-controlled, phase 3 trial in endemic areas of Brazil

www.thelancet.com/journals/lan...
Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in adolescents: final results from a 12-month, double-blind, randomised, placebo-controlled, phase 3 trial in endemic areas of ...
VLA1553 was generally safe and induced seroprotective titres up to 12 months in nearly all adolescents, with favourable safety data in those who were seropositive. The data support the use of VLA1553 ...
www.thelancet.com
December 9, 2025 at 2:01 PM